Phase II study of irinotecan (CPT-11) in patients with advanced colorectal cancer resistant to 5-fluorouracil based chemotherapy.

被引：0
|
作者：
Salinas, P
Lara, MA
de Septién, CFM
Feliu, J
Espinosa, E
de Castro, J
García-Girón, C
机构：
[1] Hosp Gen Yague, Burgos, Spain
[2] Hosp La Paz, Madrid, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [31] 5-fluorouracil as a protracted continuous infusion plus irinotecan (CPT-11) in patients with advanced colorectal cancer treated with fluoropyrimidine-based regimens as first line
    Sastre, J
    Alfonso, R
    Macías, JA
    Manrique, I
    Flores, L
    Díaz-Rubio, E
    ANTI-CANCER DRUGS, 2003, 14 (07) : 543 - 547
  • [32] 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) versus CPT-11 followed by 5-FU/LV at relapse in patients with advanced colorectal carcinoma. Phase III randomized study
    Tsavaris, N.
    Kosmas, C.
    Skopelitis, E.
    Papadoniou, N.
    Polyzos, A.
    Zografos, G.
    Diamartis, N.
    Ntokou, A.
    Tsaousi, S.
    Sarantonis, I
    Adoniou, E.
    Gryniatsos, J.
    Felekouras, E.
    Papalambros, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 81 - 81
  • [33] Multicenter phase II study of CPT-11 fractionated over two days with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer
    Recchia, F
    Nuzzo, A
    Lalli, A
    Di Lullo, L
    De Filippis, S
    Saggio, G
    Di Blasio, A
    Rea, S
    ANTICANCER RESEARCH, 2003, 23 (3C) : 2903 - 2908
  • [34] A phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy
    Cunningham, D
    Glimelius, B
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 6 - 12
  • [35] Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: A phase II trial
    Souglakos, J
    Pallis, A
    Kakolyris, S
    Mavroudis, D
    Androulakis, N
    Kouroussis, C
    Agelaki, S
    Xenidis, N
    Milaki, G
    Georgoulias, V
    ONCOLOGY, 2005, 69 (05) : 384 - 390
  • [36] Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study
    Tsavaris, N
    Ziras, N
    Kosmas, C
    Giannakakis, T
    Gouveris, P
    Vadiaka, M
    Dimitrakopoulos, A
    Karadima, D
    Rokana, S
    Papalambros, E
    Papastratis, G
    Margaris, H
    Tsipras, H
    Polyzos, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (06) : 514 - 519
  • [37] Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer
    Tsunoda, A.
    Yasuda, N.
    Nakao, K.
    Narita, K.
    Yamazaki, K.
    Watanabe, M.
    Suzuki, N.
    Kusano, M.
    ONCOLOGY, 2007, 72 (1-2) : 58 - 63
  • [38] Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study
    N. Tsavaris
    N. Ziras
    C. Kosmas
    T. Giannakakis
    P. Gouveris
    M. Vadiaka
    A. Dimitrakopoulos
    D. Karadima
    S. Rokana
    E. Papalambros
    G. Papastratis
    H. Margaris
    H. Tsipras
    A. Polyzos
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 514 - 519
  • [39] Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma - A phase III randomized study
    Tsavaris, Nicolas
    Kosmas, Christos
    Skopelitis, Helias
    Papadoniou, Nicitas
    Polyzos, Aristidis
    Zografos, George
    Adoniou, Efstathios
    Gryniatsos, John
    Felekouras, Evangelos
    Zacharakis, Michalis
    Sigala, Francheska
    Bacoyiannis, Christos
    Papastratis, George
    Papalambros, Efstathios
    CHEMOTHERAPY, 2007, 53 (04) : 282 - 291
  • [40] A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix
    Irvin, WP
    Price, FV
    Bailey, H
    Gelder, M
    Rosenbluth, R
    Durivage, HJ
    Potkul, RK
    CANCER, 1998, 82 (02) : 328 - 333
12345